MetaCap

Who Owns MapLight Therapeutics Stock?

NASDAQ: MPLTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.94-0.48 (-7.48%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
58.64%
Institutional holders
141
  • Institutions 47.8%
  • Insiders 52.2%
  • Public and other 0.0%

Who owns MapLight Therapeutics stock?

Institutional investors own about 58.6% of MapLight Therapeutics's shares, spread across 141 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 52.19% of MPLT.

The largest institutional holders are FCPM III Services B.V. (7.97%), Goldman Sachs Group Inc (6.48%) and Nan Fung Group Holdings Limited (4.14%). Together, the top 10 institutions control 36.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their MPLT positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of MPLT

MapLight Therapeutics top institutional holders
InstitutionShares% HeldChange
FCPM III Services B.V.4.43M7.97%+37.3%
Goldman Sachs Group Inc3.60M6.48%+84.8%
Nan Fung Group Holdings Limited2.30M4.14%+136.8%
Novo Holdings A/S2.09M3.75%-43.4%
Blackrock Inc.1.71M3.08%+67.1%
FMR, LLC1.54M2.77%+87.2%
Deep Track Capital, Lp1.32M2.37%+100.0%
Baker Bros. Advisors, LP1.17M2.10%+219.9%
Price (T.Rowe) Associates Inc1.13M2.04%-20.4%
T. Rowe Price Investment Management, Inc.945.22K1.70%-66.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of MPLT

MapLight Therapeutics top fund holders
FundShares% Held
T. Rowe Price Small-Cap Stock Fund, Inc.625.05K1.12%
T. Rowe Price Small-Cap Value Fund, Inc.605.60K1.09%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund552.28K0.99%
TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust411.66K0.74%
SmallCap World Fund Inc404.39K0.73%
T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U.402.79K0.72%
T. Rowe Price New Horizons Fund, Inc.398.81K0.72%
T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd.342.34K0.62%
iShares Trust-iShares Russell 2000 ETF322.94K0.58%
TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust293.79K0.53%

Frequently asked questions

Who is the largest shareholder of MapLight Therapeutics?

FCPM III Services B.V. is the largest institutional shareholder of MPLT, owning 7.97% of shares outstanding (4.43M shares) as of its latest 13F filing.

What percentage of MapLight Therapeutics is owned by institutions?

Institutions own about 58.6% of MPLT shares and 122.7% of the public float.

How much of MapLight Therapeutics do insiders own?

Insiders, such as officers and directors, own about 52.19% of MPLT shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related